Clinical Trial Update: Copenhagen Head Injury Ciclosporin (CHIC) Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Copenhagen Head Injury Ciclosporin (CHIC) study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Ciclosporin (cyclosporine)

Snippet

Sponsor: NeuroVive Pharmaceutical AB | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED